Plott Ronald Todd: insider trades.
Plott Ronald Todd reported 4 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 3 open-market purchases ($27K) and 0 sales, across 1 company.
- Transactions
- 4
- Purchases (P)
- 3
- Sales (S)
- 0
- Companies
- 1
- Name as filed
- Plott Ronald Todd
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | Director | 4 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-29 | Phio Pharmaceuticals Corp. | P | 5,000 | $1.04 | 42,000 | Form 4 |
| 2026-09-28 | Phio Pharmaceuticals Corp. | P | 5,000 | $1.03 | 37,000 | Form 4 |
| 2026-09-28 | Phio Pharmaceuticals Corp. | A | 17,000 | $0 | 32,000 | Form 4 |
| 2026-08-19 | Phio Pharmaceuticals Corp. | P | 15,000 | $1.14 | 15,000 | Form 4 |
Questions
What stock did Plott Ronald Todd buy or sell?
Plott Ronald Todd reported 4 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 3 open-market purchases ($27K) and 0 sales, across 1 company.
Is Plott Ronald Todd the same person as other filers with this name?
This page covers SEC CIK 1768337 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/plott-ronald-todd-1768337.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.